학술논문
PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy...
Document Type
Article
Author
Grose, Derek B.; Jamieson, Nigel Balfour; Radhakrishna, Ganesh; Hawkins, Maria A.; McIntosh, David; Duffton, Aileen; Graham, Janet Shirley; Goody, Rebecca; Houston, Peter; Bradley, Sarah; Ravikumar, Reena; Christie, Alan; Dixon-Hughes, Judith; Kelly, Caroline; Paterson, Lucy; Biankin, Andrew V.; McKay, Colin J.; Chang, David Kuang-Fu
Source
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p669-669, 117p
Subject
Language
ISSN
0732183X